Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...

Ditch the painkillers! While they can provide temporary relief, there are other ways to numb pain without medication. Find ...

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine), an oral NaV1.8 inhibitor, as a treatment for acute pain, representing ...

In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...

The Best Tail For Balance | Bindi Irwin Wants Kids To Become 'Wildlife Warriors' February 27, 2025 • The bone and joint structures in mammal tails help them keep their balance. Could those ...

The Best Tail For Balance | Bindi Irwin Wants Kids To Become 'Wildlife Warriors' February 27, 2025 • The bone and joint structures in mammal tails help them keep their balance. Could those ...

The U.S. Food and Drug Administration said last week it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ... for its ambitious drug pipeline that involves winning FDA approval ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

Not a moment too soon: a drug is on the market that is effective in treating pain but is not addictive. Its generic name is suzetrigine — sold under the name Journavx — and it took 25 years to develop ...